Á lódáil...
Anti‐FIRΔexon2 autoantibody as a novel indicator for better overall survival in gastric cancer
There is no clinically available biomarker for efficiently indicating the overall survival or therapy response of gastric cancer (GC). The autoantibodies (Abs) in the sera of anti‐far‐upstream element‐binding protein‐interacting repressor‐lacking exon2 (FIRΔexon2), anti‐sorting nexin 15, and anti‐sp...
Na minha lista:
| Foilsithe in: | Cancer Sci |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe: |
John Wiley and Sons Inc.
2021
|
| Ábhair: | |
| Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7894018/ https://ncbi.nlm.nih.gov/pubmed/33306856 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14767 |
| Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|